Melasma and Lasers: Why the Strongest Setting Is Usually the Wrong One

Walk into almost any laser consultation in Beverly Hills and melasma will come up. It is one of the most common pigment complaints in the area, driven by year-round sun exposure, hormonal factors, and a patient population that watches its skin closely. It is also the condition where the popular logic of lasers, that more energy means better clearance, fails most reliably. This piece looks at what the mechanism actually says.

The myth: melasma is a stain that a laser can blast away. The comparison patients usually reach for is tattoo removal or sun spot treatment, where concentrated light shatters pigment and the body clears the debris. Melasma looks similar on the surface, brownish patches typically across the cheeks, forehead, and upper lip, but it behaves nothing like a static deposit of pigment. For an independent overview, see Melasma and pigmentation: diagnosis and treatment.

The reality: melasma is an activity problem, not a storage problem. In melasma, melanocytes, the cells that manufacture pigment, are abnormally reactive. They respond to ultraviolet light, visible light, heat, hormones, and inflammation by producing more melanin. Histology studies also show increased vascularity and photodamaged support tissue beneath melasma patches, which appears to feed the overactivity. So the pigment you see is output, and the factory producing it is hypersensitive to exactly the kind of stimulus a laser delivers.

Why aggressive treatment rebounds. High-fluence lasers and deep resurfacing generate significant heat and inflammation. In normal skin, that inflammation resolves and remodeling follows. In melasma-prone skin, the inflammatory cascade signals melanocytes to ramp up production, a process called post-inflammatory hyperpigmentation. Patients can look clearer for two to six weeks while the treated pigment sheds, then watch the patches return darker than baseline. This rebound is well documented and is the reason experienced clinicians treat melasma cautiously regardless of how advanced their device is.

What lasers can legitimately do. The approaches with the best track record share one theme: low energy, delivered conservatively. Low-fluence Q-switched 1064 nm treatments, sometimes marketed as laser toning, use energy levels well below the threshold that destroys melanocytes, aiming instead to fragment melanin within cells with minimal heat. Picosecond lasers at similarly low settings pursue the same goal with shorter pulses, which shifts the effect further toward mechanical fragmentation and away from heat. Low-density fractional 1927 nm thulium treatments target pigment in the upper skin layers and can help shuttle melanin out through microscopic healing channels. All of these can lighten melasma. None of them cure it, and each carries risk if overused. Repeated laser toning sessions, for example, have been associated with patchy hypopigmentation, small confetti-like white spots caused by exhausted or damaged melanocytes, which is harder to correct than the melasma itself.

Lasers are adjuncts, not first-line therapy. The evidence base still places topical and oral therapy at the foundation. Triple combination creams containing hydroquinone, a retinoid, and a mild corticosteroid remain the benchmark for suppressing pigment production. Oral or topical tranexamic acid, prescribed and monitored by a physician, addresses the vascular and inflammatory contributors. Lasers make the most sense layered on top of this foundation, used to accelerate clearance while the topicals hold melanocyte activity down. A laser used alone, without pigment suppression before and after, is treating the output while leaving the factory running.

Skin tone changes the math. Melasma is most common in Fitzpatrick types III to V, and these are also the skin types most prone to post-inflammatory hyperpigmentation. That combination narrows the safe operating window considerably. Reasonable safeguards include a small test spot several weeks before full treatment, pre-treatment with pigment-suppressing topicals, conservative settings on the first session, and longer intervals between sessions than a patient might expect, often four to six weeks or more.

Sun protection is not optional, and visible light counts. Standard sunscreens block ultraviolet but not visible light, and visible light alone can stimulate pigment in darker skin types. Tinted sunscreens containing iron oxides block a meaningful portion of visible light and are consistently recommended in melasma protocols. In a sunny climate, skipping this step can undo months of treatment.

Questions worth asking at a consultation. How does the clinic distinguish melasma from sun spots, ideally with a Wood's lamp or dermoscopy? What topical regimen will run alongside the laser plan? What settings will be used for the first session, and why? What is the plan if pigment darkens after treatment? A provider who answers with specifics about suppression, maintenance, and conservative energy is describing melasma treatment. A provider promising permanent removal in a fixed number of sessions is describing a condition melasma is not.

The honest framing is that melasma is managed, not erased. Lasers have a real role in that management, but only when the settings respect the biology. In this condition, restraint is the advanced technique.

Related reading: Melasma and Lasers: Why the Most Requested Fix Is Also the Easiest to Get Wrong.